Display options
Share it on

Front Physiol. 2015 Jul 16;6:199. doi: 10.3389/fphys.2015.00199. eCollection 2015.

Modifications of myofilament protein phosphorylation and function in response to cardiac arrest induced in a swine model.

Frontiers in physiology

Mike Woodward, Michael J Previs, Timothy J Mader, Edward P Debold

Affiliations

  1. Molecular and Cellular Biology Graduate Program, University of Massachusetts Amherst, MA, USA.
  2. Department of Molecular Physiology and Biophysics, University of Vermont Burlington, VT, USA.
  3. Department of Emergency Medicine, Baystate Medical Center/Tufts University School of Medicine Springfield, MA, USA.
  4. Molecular and Cellular Biology Graduate Program, University of Massachusetts Amherst, MA, USA ; Muscle Biophysics Lab, Department of Kinesiology, University of Massachusetts Amherst, MA, USA.

PMID: 26236240 PMCID: PMC4503891 DOI: 10.3389/fphys.2015.00199

Abstract

Cardiac arrest is a prevalent condition with a poor prognosis, attributable in part to persistent myocardial dysfunction following resuscitation. The molecular basis of this dysfunction remains unclear. We induced cardiac arrest in a porcine model of acute sudden death and assessed the impact of ischemia and reperfusion on the molecular function of isolated cardiac contractile proteins. Cardiac arrest was electrically induced, left untreated for 12 min, and followed by a resuscitation protocol. With successful resuscitations, the heart was reperfused for 2 h (IR2) and the muscle harvested. In failed resuscitations, tissue samples were taken following the failed efforts (IDNR). Actin filament velocity, using myosin isolated from IR2 or IDNR cardiac tissue, was nearly identical to myosin from the control tissue in a motility assay. However, both maximal velocity (25% faster than control) and calcium sensitivity (pCa50 6.57 ± 0.04 IDNR vs. 6.34 ± 0.07 control) were significantly (p < 0.05) enhanced using native thin filaments (actin+troponin+tropomyosin) from IDNR samples, suggesting that the enhanced velocity is mediated through an alteration in muscle regulatory proteins (troponin+tropomyosin). Mass spectrometry analysis showed that only samples from the IR2 had an increase in total phosphorylation levels of troponin (Tn) and tropomyosin (Tm), but both IR2 and IDNR samples demonstrated a significant shift from mono-phosphorylated to bis-phosphorylated forms of the inhibitory subunit of Tn (TnI) compared to control. This suggests that the shift to bis-phosphorylation of TnI is associated with the enhanced function in IDNR, but this effect may be attenuated when phosphorylation of Tm is increased in tandem, as observed for IR2. There are likely many other molecular changes induced following cardiac arrest, but to our knowledge, these data provide the first evidence that this form cardiac arrest can alter the in vitro function of the cardiac contractile proteins.

Keywords: cardiac arrest; motility; myosin; phosphorylation; resuscitation; troponin

References

  1. Circulation. 2008 Dec 2;118(23):2452-83 - PubMed
  2. J Mol Cell Cardiol. 2005 Jan;38(1):119-25 - PubMed
  3. Methods Enzymol. 1982;85 Pt B:55-71 - PubMed
  4. Circ Res. 1992 Feb;70(2):302-13 - PubMed
  5. J Biol Chem. 1989 Nov 15;264(32):18890-5 - PubMed
  6. Biomark Med. 2012 Feb;6(1):69-72 - PubMed
  7. Cell Motil Cytoskeleton. 2009 Jan;66(1):10-23 - PubMed
  8. Biochemistry. 2006 Mar 21;45(11):3794-804 - PubMed
  9. J Am Coll Cardiol. 1996 Jul;28(1):232-40 - PubMed
  10. Circ Res. 2000 Apr 14;86(7):737-44 - PubMed
  11. Coron Artery Dis. 2001 Aug;12(5):343-7 - PubMed
  12. Circ Res. 1997 Mar;80(3):393-9 - PubMed
  13. J Clin Invest. 1990 Mar;85(3):706-13 - PubMed
  14. Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1401-8 - PubMed
  15. J Physiol. 1992 Aug;454:467-90 - PubMed
  16. Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H654-9 - PubMed
  17. J Mol Cell Cardiol. 2008 Nov;45(5):603-7 - PubMed
  18. Circ Res. 1999 Jan 8-22;84(1):9-20 - PubMed
  19. Resuscitation. 2010 May;81(5):596-602 - PubMed
  20. Circulation. 2012 Jan 3;125(1):e2-e220 - PubMed
  21. Biochemistry. 2004 Nov 30;43(47):15058-65 - PubMed
  22. Arch Intern Med. 1994 Nov 14;154(21):2433-7 - PubMed
  23. N Engl J Med. 2001 Apr 26;344(17):1304-13 - PubMed
  24. Cardiol Clin. 2002 Feb;20(1):89-101 - PubMed
  25. J Appl Physiol (1985). 2012 Nov;113(9):1413-22 - PubMed
  26. J Mol Med (Berl). 2007 Sep;85(9):911-21 - PubMed
  27. Cytoskeleton (Hoboken). 2011 Jan;68(1):18-31 - PubMed
  28. Circ Res. 1995 Jun;76(6):1036-48 - PubMed
  29. Science. 2012 Sep 7;337(6099):1215-8 - PubMed
  30. J Mol Biol. 1995 Aug 11;251(2):191-6 - PubMed
  31. JAMA. 1999 Apr 7;281(13):1182-8 - PubMed
  32. Physiol Rev. 1999 Apr;79(2):609-34 - PubMed
  33. PLoS One. 2010 Mar 04;5(3):e9528 - PubMed
  34. Circ Res. 2003 Nov 14;93(10):917-24 - PubMed
  35. Circ Res. 1998 Feb 9;82(2):261-71 - PubMed
  36. J Muscle Res Cell Motil. 2012 Dec;33(6):449-59 - PubMed
  37. Circ Res. 1987 Feb;60(2):153-68 - PubMed
  38. Heart Fail Rev. 2012 Jan;17(1):117-28 - PubMed
  39. Anal Chem. 2008 Aug 1;80(15):5864-72 - PubMed

Publication Types

Grant support